340 related articles for article (PubMed ID: 26852313)
1. Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry.
Steunebrink LM; Vonkeman HE; ten Klooster PM; Hoekstra M; van Riel PL; van de Laar MA
Clin Rheumatol; 2016 Mar; 35(3):609-15. PubMed ID: 26852313
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
3. Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry.
Steunebrink LM; Versteeg GA; Vonkeman HE; Ten Klooster PM; Kuper HH; Zijlstra TR; van Riel PL; van de Laar MA
Arthritis Res Ther; 2016 Mar; 18():60. PubMed ID: 26956382
[TBL] [Abstract][Full Text] [Related]
4. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
Schipper LG; Vermeer M; Kuper HH; Hoekstra MO; Haagsma CJ; Den Broeder AA; van Riel P; Fransen J; van de Laar MA
Ann Rheum Dis; 2012 Jun; 71(6):845-50. PubMed ID: 22210852
[TBL] [Abstract][Full Text] [Related]
5. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).
Dougados MR; van der Heijde DM; Brault Y; Koenig AS; Logeart IS
J Rheumatol; 2014 Oct; 41(10):1922-34. PubMed ID: 25128520
[TBL] [Abstract][Full Text] [Related]
6. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.
Vermeer M; Kuper HH; Bernelot Moens HJ; Hoekstra M; Posthumus MD; van Riel PL; van de Laar MA
Arthritis Res Ther; 2012 Nov; 14(6):R254. PubMed ID: 23176083
[TBL] [Abstract][Full Text] [Related]
7. Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.
Xie W; Li J; Zhang X; Li G; Hao Y; Zhao J; Wang L; Sun X; Fan Y; Zhang Z
Clin Exp Rheumatol; 2018; 36(5):820-828. PubMed ID: 29533754
[TBL] [Abstract][Full Text] [Related]
8. Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.
Versteeg GA; Steunebrink LMM; Vonkeman HE; Ten Klooster PM; van der Bijl AE; van de Laar MAFJ
Clin Rheumatol; 2018 May; 37(5):1189-1197. PubMed ID: 29388086
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
[TBL] [Abstract][Full Text] [Related]
10. Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
Kojima T; Yabe Y; Kaneko A; Takahashi N; Funahashi K; Kato D; Hanabayashi M; Asai S; Hirabara S; Asai N; Hirano Y; Hayashi M; Miyake H; Kojima M; Ishiguro N
Rheumatology (Oxford); 2015 Jan; 54(1):113-20. PubMed ID: 25102861
[TBL] [Abstract][Full Text] [Related]
11. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
12. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
[TBL] [Abstract][Full Text] [Related]
13. Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.
Vermeer M; Kievit W; Kuper HH; Braakman-Jansen LM; Bernelot Moens HJ; Zijlstra TR; den Broeder AA; van Riel PL; Fransen J; van de Laar MA
BMC Musculoskelet Disord; 2013 Dec; 14():350. PubMed ID: 24330489
[TBL] [Abstract][Full Text] [Related]
14. Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry.
Hetland ML; Jensen DV; Krogh NS
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-141-6. PubMed ID: 25365104
[TBL] [Abstract][Full Text] [Related]
15. Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study.
Brenol CV; da Chakr RM; Andrade NP; Toni M; Laurindo IM; Brenol JC; Xavier RM
Clin Rheumatol; 2015 Oct; 34(10):1781-5. PubMed ID: 25771853
[TBL] [Abstract][Full Text] [Related]
16. Treat-to-target approach in daily clinical practice in Pakistani patients with early Rheumatoid Arthritis.
Farman S; Ahmad NM; Saeed MA; Asad K; Shabbir G
J Coll Physicians Surg Pak; 2015 Feb; 25(2):129-33. PubMed ID: 25703758
[TBL] [Abstract][Full Text] [Related]
17. Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study.
Brinkmann GH; Norvang V; Norli ES; Grøvle L; Haugen AJ; Lexberg ÅS; Rødevand E; Bakland G; Nygaard H; Krøll F; Widding-Hansen IJ; Bjørneboe O; Thunem C; Kvien T; Mjaavatten MD; Lie E
Semin Arthritis Rheum; 2019 Apr; 48(5):808-814. PubMed ID: 30205983
[TBL] [Abstract][Full Text] [Related]
18. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
Xie W; Li J; Zhang X; Sun X; Zhang Z
Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
[TBL] [Abstract][Full Text] [Related]
19. Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow-ups and predictors of achieving treatment target.
Xiang Y; Wang Q; Li H; Duan X; Fang Y; Yang P; Li Q; Wu R; Huo Y; Shi X; Wu Z; Wang Y; Jiang N; Hsieh E; Li M; Tian X; Zeng X;
Int J Rheum Dis; 2020 Dec; 23(12):1719-1727. PubMed ID: 33034424
[TBL] [Abstract][Full Text] [Related]
20. Longterm efficacy and safety of abatacept in patients with rheumatoid arthritis treated in routine clinical practice: effect of concomitant methotrexate after 24 weeks.
Takahashi N; Kojima T; Kaneko A; Kida D; Hirano Y; Fujibayashi T; Yabe Y; Takagi H; Oguchi T; Miyake H; Kato T; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Asai S; Yoshioka Y; Takemoto T; Terabe K; Asai N; Ishiguro N
J Rheumatol; 2015 May; 42(5):786-93. PubMed ID: 25834204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]